🇺🇸 FDA
Patent

US 7410641

Antibodies to insulin/IGF/relaxin family polypeptides

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7410641 (Antibodies to insulin/IGF/relaxin family polypeptides) held by Takeda Pharmaceutical Company Limited expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P1/16